MiR-21 is a Predictor for Chemoradioresistance and a Novel Therapeutic Target in Head and Neck Squamous Cell Carcinoma

Hajime Ishinaga(Mie University), Kazuhiko Takeuchi(Mie University)
Research Square
November 12, 2021
10.21203/rs.3.rs-1023448/v1
Cited by 0

Related Papers

RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma
|Journal of Experimental & Clinical Cancer Research|2017|50
The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma
|Journal of Radiation Research|2023|8